Astragaloside IV combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway

Astragaloside IV (AS-IV) in improving liver cirrhosis injury in rats and its effect on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mechanistic target of rapamycin (mTOR) signaling pathway were observed. Rat model of liver cirrhosis was induced by injection of carbon tetrachloride (CC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Rendong, Liu, Haidong, Chen, Ru, Sheng, Yunjian, Liu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307369/
https://www.ncbi.nlm.nih.gov/pubmed/30651810
http://dx.doi.org/10.3892/etm.2018.6966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307369/
https://www.ncbi.nlm.nih.gov/pubmed/30651810
http://dx.doi.org/10.3892/etm.2018.6966

Ejemplares similares